Calumet Historical Financial Ratios
CLMT Stock | USD 22.54 0.14 0.63% |
Calumet Specialty is presently reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.096, Days Sales Outstanding of 26.35 or Invested Capital of 0.0 will help investors to properly organize and evaluate Calumet Specialty financial condition quickly.
Calumet |
About Calumet Financial Ratios Analysis
Calumet SpecialtyFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Calumet Specialty investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Calumet financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Calumet Specialty history.
Calumet Specialty Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Calumet Specialty stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Calumet Specialty sales, a figure that is much harder to manipulate than other Calumet Specialty Products multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Calumet Specialty Products dividend as a percentage of Calumet Specialty stock price. Calumet Specialty dividend yield is a measure of Calumet Specialty stock productivity, which can be interpreted as interest rate earned on an Calumet Specialty investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Earnings Yield
The inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company.Most ratios from Calumet Specialty's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Calumet Specialty current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Calumet Specialty Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, Calumet Specialty's PE Ratio is comparatively stable compared to the past year. Return On Tangible Assets is likely to gain to 0.02 in 2024, whereas PTB Ratio is likely to drop (3.06) in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 9.98 | 9.81 | 11.58 | 14.29 | Days Of Inventory On Hand | 39.67 | 41.92 | 43.01 | 30.91 |
Calumet Specialty fundamentals Correlations
Click cells to compare fundamentals
Calumet Specialty Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Calumet Specialty fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 0.0827 | 0.11 | 0.33 | 0.29 | 0.34 | 0.26 | |
Ptb Ratio | (26.93) | (19.94) | (103.22) | (4.65) | (2.91) | (3.06) | |
Days Sales Outstanding | 19.93 | 25.81 | 29.33 | 19.06 | 24.99 | 26.35 | |
Book Value Per Share | 0.28 | (1.64) | (4.88) | (3.63) | (3.06) | (2.9) | |
Free Cash Flow Yield | 0.48 | 0.0766 | (0.12) | (0.33) | (0.2) | (0.21) | |
Operating Cash Flow Per Share | 2.45 | 0.8 | (0.56) | 1.27 | (0.19) | (0.18) | |
Stock Based Compensation To Revenue | 0.001709 | 0.002425 | 0.0161 | 0.003691 | 0.003516 | 0.002402 | |
Pb Ratio | (26.93) | (19.94) | (103.22) | (4.65) | (2.91) | (3.06) | |
Free Cash Flow Per Share | 1.75 | 0.24 | (1.61) | (5.49) | (3.58) | (3.4) | |
Roic | 0.0981 | (0.0492) | (0.052) | 0.0912 | 0.19 | 0.2 | |
Inventory Turnover | 10.26 | 8.07 | 9.2 | 8.71 | 8.49 | 11.2 | |
Net Income Per Share | (0.56) | (1.9) | (3.29) | (2.17) | 0.6 | 0.63 | |
Days Of Inventory On Hand | 35.59 | 45.21 | 39.67 | 41.92 | 43.01 | 30.91 | |
Payables Turnover | 13.04 | 11.48 | 9.98 | 9.81 | 11.58 | 14.29 | |
Sales General And Administrative To Revenue | 0.0752 | 0.0891 | 0.048 | 0.0301 | 0.0318 | 0.0398 | |
Capex To Revenue | 0.0159 | 0.0194 | 0.0263 | 0.11 | 0.065 | 0.0491 | |
Cash Per Share | 0.24 | 1.4 | 0.48 | 0.44 | 0.0987 | 0.0937 | |
Pocfratio | 1.49 | 3.91 | (23.69) | 13.31 | (96.04) | (91.24) | |
Interest Coverage | 0.96 | (0.54) | (0.55) | 0.76 | 1.21 | 1.14 | |
Capex To Operating Cash Flow | 0.29 | 0.7 | (1.88) | 5.33 | (18.24) | (17.33) | |
Pfcf Ratio | 2.08 | 13.05 | (8.22) | (3.07) | (4.99) | (4.74) | |
Days Payables Outstanding | 28.0 | 31.8 | 36.56 | 37.21 | 31.52 | 24.5 | |
Income Quality | (4.4) | (0.42) | 0.17 | (0.59) | (0.32) | (0.3) | |
Roe | 4.11 | 12.11 | 25.75 | 0.6 | (0.0978) | (0.093) | |
Ev To Operating Cash Flow | 8.19 | 24.59 | (58.84) | 29.54 | (242.51) | (230.39) | |
Pe Ratio | (6.55) | (1.65) | (4.01) | (7.8) | 29.75 | 31.76 | |
Return On Tangible Assets | (0.0301) | (0.027) | (0.0944) | (0.0678) | 0.0189 | 0.0198 | |
Ev To Free Cash Flow | 11.47 | 82.15 | (20.4) | (6.82) | (12.6) | (11.97) | |
Earnings Yield | (0.15) | (0.61) | (0.25) | (0.13) | 0.0336 | 0.0353 | |
Net Debt To E B I T D A | 5.84 | 13.26 | 99.12 | 12.81 | 5.22 | 5.12 | |
Current Ratio | 0.91 | 0.98 | 0.7 | 0.61 | 0.71 | 0.68 | |
Tangible Book Value Per Share | (2.83) | (4.58) | (7.65) | (6.26) | (5.57) | (5.29) | |
Receivables Turnover | 18.32 | 14.14 | 12.44 | 19.15 | 14.61 | 12.91 | |
Graham Number | 1.3 | 2.59 | 3.08 | 13.29 | 9.11 | 8.65 | |
Shareholders Equity Per Share | (0.14) | (0.16) | (0.13) | (3.63) | (6.14) | (5.83) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.